These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Management of invasive mycoses in hematology patients: current approaches. Perfect JR Oncology (Williston Park); 2004 Nov; 18(13 Suppl 7):5-14. PubMed ID: 15651177 [TBL] [Abstract][Full Text] [Related]
7. Caspofungin in the treatment of azole-refractory esophageal candidiasis in kidney transplant recipients. Veroux M; Macarone M; Fiamingo P; Cappello D; Gagliano M; Di Mare M; Vizcarra D; Spataro M; Giuffrida G; Sorbello M; Severino V; Veroux P Transplant Proc; 2006 May; 38(4):1037-9. PubMed ID: 16757256 [TBL] [Abstract][Full Text] [Related]
8. Caspofungin: a review of its use in the treatment of fungal infections. McCormack PL; Perry CM Drugs; 2005; 65(14):2049-68. PubMed ID: 16162025 [TBL] [Abstract][Full Text] [Related]
9. Use of newer antifungal therapies in clinical practice: what do the data tell us? Perfect JR Oncology (Williston Park); 2004 Nov; 18(13 Suppl 7):15-23. PubMed ID: 15651178 [TBL] [Abstract][Full Text] [Related]
10. Caspofungin acetate for treatment of invasive fungal infections. Pacetti SA; Gelone SP Ann Pharmacother; 2003 Jan; 37(1):90-8. PubMed ID: 12503942 [TBL] [Abstract][Full Text] [Related]
11. Caspofungin: a review of its use in oesophageal candidiasis, invasive candidiasis and invasive aspergillosis. Keating G; Figgitt D Drugs; 2003; 63(20):2235-63. PubMed ID: 14498760 [TBL] [Abstract][Full Text] [Related]
12. Management of mycoses in surgical patients -- review of the literature. Holzheimer RG; Dralle H Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912 [TBL] [Abstract][Full Text] [Related]
13. [Future role of micafungin in the treatment of invasive mycoses caused by filamentous fungi]. Salavert-Lletí M; Zaragoza-Crespo R Rev Iberoam Micol; 2009 Mar; 26(1):81-9. PubMed ID: 19463284 [TBL] [Abstract][Full Text] [Related]